Establishment Labs Share Price (NASDAQ: ESTA)

$41.18

▲

0.18

(0.44%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Establishment Labs Stock chart to analyse performance

Establishment Labs stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$40.87
Today's High:$41.48
$41.18
0.75%
Downside
Day's Volatility :1.47%
Upside
0.72%
52 Weeks Low:$26.56
52 Weeks High:$50.85
$41.18
35.51%
Downside
52 Weeks Volatility :47.78%
Upside
19.02%

Establishment Labs Stock Returns

Period	Establishment Labs Holdings Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	21.58%	3.6%	0.0%
6 Months	-3.68%	-7.7%	0.0%
1 Year	-2.13%	-12.6%	0.0%
3 Years	-31.57%	9.5%	-4.7%

Establishment Labs Holdings Inc Key Stats

Check Establishment Labs key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$41.0
Open	$40.87
Today's High	$41.48
Today's Low	$40.87
Market Capitalization	$1.2B
Today's Volume	$205.8K
52 Week High	$50.85
52 Week Low	$26.555
Revenue TTM	$177.4M
EBITDA	$-54.0M
Earnings Per Share (EPS)	$-3.08
Profit Margin	-49.89%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-261.18%

Stock Returns calculator for Establishment Labs Stock including INR - Dollar returns

The Establishment Labs stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Establishment Labs investment value today

Current value as on today

₹95,158

Returns

₹4,842

(-4.84%)

Returns from Establishment Labs Stock

₹10,127 (-10.13%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Establishment Labs Stock

-45%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Establishment Labs Stock from India on INDmoney has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Establishment Labs Holdings Inc

Name
Holdings %
Name
Holdings %
JW Asset Management, LLC
10.68%
RTW INVESTMENTS, LLC
8.92%
Brown Advisory Holdings Inc
7.40%
Nantahala Capital Management, LLC
6.13%
Findell Capital Management LLC
4.76%
Tyro Capital Management LLC
3.68%

Analyst Recommendation on Establishment Labs Stock

Rating

Trend

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Establishment Labs(by analysts ranked 0 to 5 stars)

Establishment Labs Share Price Target

What analysts predicted

Upside of 34.64%

Target:

$55.44

Current:

$41.18

Establishment Labs share price target is $55.44, a slight Upside of 34.64% compared to current price of $41.18 as per analysts' prediction.

Establishment Labs Stock Insights

Price Movement
In the last 7 days, ESTA stock has moved down by -5.4%
Increasing Revenue
Revenue is up for the last 2 quarters, 41.37M → 51.3M (in $), with an average increase of 19.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -34.53M → -16.59M (in $), with an average increase of 45.8% per quarter
ESTA vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 38.9%
ESTA vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 196.6%
Price to Sales
ForESTA every $1 of sales, investors are willing to pay $6.7, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Establishment Labs Holdings Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$89.6M	↑ 46.33%
Net Income	$-38.2M	↑ 80.82%
Net Profit Margin	-42.59%	↓ 8.12%

	FY20	Y/Y Change
Revenue	$84.7M	↓ 5.46%
Net Income	$-38.1M	↓ 0.08%
Net Profit Margin	-45.02%	↓ 2.43%

	FY21	Y/Y Change
Revenue	$126.7M	↑ 49.61%
Net Income	$-41.1M	↑ 7.92%
Net Profit Margin	-32.47%	↑ 12.55%

	FY22	Y/Y Change
Revenue	$161.7M	↑ 27.64%
Net Income	$-75.2M	↑ 82.82%
Net Profit Margin	-46.51%	↓ 14.04%

	FY23	Y/Y Change
Revenue	$165.2M	↑ 2.13%
Net Income	$-78.5M	↑ 4.38%
Net Profit Margin	-47.53%	↓ 1.02%

	FY24	Y/Y Change
Revenue	$166.0M	↑ 0.53%
Net Income	$-84.6M	↑ 7.76%
Net Profit Margin	-50.95%	↓ 3.42%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$37.2M	↑ 17.77%
Net Income	$-16.2M	↓ 21.13%
Net Profit Margin	-43.59%	↑ 21.5%

	Q2 FY24	Q/Q Change
Revenue	$44.1M	↑ 18.7%
Net Income	$-17.2M	↑ 6.04%
Net Profit Margin	-38.94%	↑ 4.65%

	Q3 FY24	Q/Q Change
Revenue	$40.2M	↓ 8.82%
Net Income	$-16.7M	↓ 2.9%
Net Profit Margin	-41.47%	↓ 2.53%

	Q4 FY24	Q/Q Change
Revenue	$44.5M	↑ 10.66%
Net Income	$-34.5M	↑ 107.0%
Net Profit Margin	-77.57%	↓ 36.1%

	Q1 FY25	Q/Q Change
Revenue	$41.4M	↓ 7.05%
Net Income	$-20.7M	↓ 40.02%
Net Profit Margin	-50.05%	↑ 27.52%

	Q2 FY25	Q/Q Change
Revenue	$51.3M	↑ 23.98%
Net Income	$-16.6M	↓ 19.88%
Net Profit Margin	-32.35%	↑ 17.7%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$54.9M	↑ 51.89%

	FY20	Y/Y Change
Profit	$52.5M	↓ 4.3%

	FY21	Y/Y Change
Profit	$85.4M	↑ 62.67%

	FY22	Y/Y Change
Profit	$106.6M	↑ 24.81%

	FY23	Y/Y Change
Profit	$107.0M	↑ 0.36%

	FY24	Y/Y Change
Profit	$109.5M	↑ 2.38%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$24.4M	↑ 18.44%

	Q2 FY24	Q/Q Change
Profit	$28.9M	↑ 18.69%

	Q3 FY24	Q/Q Change
Profit	$25.7M	↓ 11.12%

	Q4 FY24	Q/Q Change
Profit	$30.5M	↑ 18.57%

	Q1 FY25	Q/Q Change
Profit	$27.8M	↓ 8.8%

	Q2 FY25	Q/Q Change
Profit	$35.3M	↑ 26.84%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-30.0M	↓ 11.52%
Investing Cash Flow	$-7.8M	↑ 35.51%
Financing Cash Flow	$22.8M	↓ 72.05%

	FY20	Y/Y Change
Operating Cash Flow	$-12.5M	↓ 58.28%
Investing Cash Flow	$-5.6M	↓ 28.42%
Financing Cash Flow	$64.7M	↑ 183.78%

	FY21	Y/Y Change
Operating Cash Flow	$-27.5M	↑ 120.08%
Investing Cash Flow	$-7.2M	↑ 28.85%
Financing Cash Flow	$4.1M	↓ 93.73%

	FY22	Y/Y Change
Operating Cash Flow	$-52.2M	↑ 89.47%
Investing Cash Flow	$-34.8M	↑ 385.7%
Financing Cash Flow	$100.3M	↑ 2374.21%

	FY23	Y/Y Change
Operating Cash Flow	$-88.5M	↑ 69.68%
Investing Cash Flow	$-24.5M	↓ 29.44%
Financing Cash Flow	$86.2M	↓ 13.99%

	FY24	Y/Y Change
Operating Cash Flow	$-58.5M	↓ 33.89%
Investing Cash Flow	$-15.6M	↓ 36.4%
Financing Cash Flow	$125.9M	↑ 46.0%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-11.2M	↑ 36.74%
Investing Cash Flow	$-6.6M	↑ 40.15%
Financing Cash Flow	$51.0M	↑ 78427.69%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-14.2M	↑ 27.18%
Investing Cash Flow	$-4.4M	↓ 33.39%
Financing Cash Flow	$389.0K	↓ 99.24%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-12.5M	↓ 12.14%
Investing Cash Flow	$-2.8M	↓ 37.35%
Financing Cash Flow	$-28.0K	↓ 107.2%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-20.7M	↑ 66.51%
Investing Cash Flow	$-1.8M	↓ 34.21%
Financing Cash Flow	$74.5M	↓ 266139.29%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-20.7M	↓ 0.12%
Investing Cash Flow	$-1.3M	↓ 26.55%
Financing Cash Flow	$-203.0K	↓ 100.27%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-18.8M	↓ 9.52%
Investing Cash Flow	$-2.1M	↑ 55.01%
Financing Cash Flow	$5.1M	↓ 2626.6%

Establishment Labs Technicals Summary

Sell

Neutral

Buy

Establishment Labs is currently in a neutral trading position according to technical analysis indicators.

Establishment Labs Holdings Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Establishment Labs Holdings Inc	-1.56%	-3.68%	-2.13%	-31.57%	119.68%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Establishment Labs Holdings Inc	NA	NA	NA	-2.06	-2.61	-0.13	NA	0.79
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Establishment Labs Holdings Inc	Buy	$1.2B	119.68%	NA	-49.89%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Establishment Labs Holdings Inc

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Organization	Establishment Labs
Employees	1056
CEO	Mr. Fillipo Peter Caldini
Industry	Health Technology

Key Management of Establishment Labs Holdings Inc

Name	Title
Mr. Fillipo Peter Caldini	CEO & Director
Mr. Juan Jose Chacon Quiros	Founder & Executive Director
Mr. Rajbir Singh Denhoy	Chief Financial Officer
Mr. S. Ross Mansbach	General Counsel, Chief Compliance Officer & Chief Human Resources Officer
Mr. Roberto de Mezerville	Chief Technology Officer
Mr. Ivan Bilic	Senior Vice President of Commercial Operations - OUS
Mr. Jeff Ehrhardt	Senior VP & GM of North America

Important FAQs about investing in ESTA Stock from India :

What is Establishment Labs share price today?

Establishment Labs share price today is $41.18 as on August 30, 2025 at 1:29 am IST at the close of the market. Establishment Labs share today touched a day high of $41.48 and a low of $40.87.

What is the 52 week high and 52 week low for Establishment Labs share?

Establishment Labs share touched a 52 week high of $50.85 and a 52 week low of $26.56. Establishment Labs stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $41.18, lower by 19.02% versus the 52 week high.

How to invest in Establishment Labs Stock (ESTA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Establishment Labs on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Establishment Labs Shares that will get you 0.0364 shares as per Establishment Labs share price of $41.18 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Establishment Labs Stock (ESTA) from India?

Indian investors can start investing in Establishment Labs (ESTA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Establishment Labs stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Establishment Labs share’s latest price of $41.18 as on August 30, 2025 at 1:29 am IST, you will get 0.2428 shares of Establishment Labs. Learn more about fractional shares .

What are the returns that Establishment Labs has given to Indian investors in the last 5 years?

Establishment Labs stock has given 119.68% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?